ELLEN BARNES: Open Payments
NPI 1609259977 · KEARNEY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$808 in 29 payments from 15 companies in 2025. Trend: 2023 $624 · 2024 $344 · 2025 $808
Food & beverage: $620Education: $188
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $276 |
| SANOFI-AVENTIS U.S. LLC | 1 | $98 |
| Regeneron Healthcare Solutions, Inc. | 1 | $90 |
| Novartis Pharmaceuticals Corporation | 5 | $74 |
| Verona Pharma, Inc. | 3 | $53 |
| Phathom Pharmaceuticals, Inc. | 5 | $44 |
| Kerecis Limited | 1 | $26 |
| GENZYME CORPORATION | 1 | $24 |
| PFIZER INC. | 1 | $21 |
| Merz Pharmaceuticals, LLC | 1 | $21 |
Products named: DUPIXENT, TEZSPIRE, BREZTRI, LEQVIO, Ohtuvayre, VOQUEZNA, Kerecis SurgiClose, FASENRA.
Industry payments across NE — which companies pay providers there.
